<SEC-DOCUMENT>0001477932-15-006753.txt : 20151104
<SEC-HEADER>0001477932-15-006753.hdr.sgml : 20151104
<ACCEPTANCE-DATETIME>20151104151528
ACCESSION NUMBER:		0001477932-15-006753
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20151008
FILED AS OF DATE:		20151104
DATE AS OF CHANGE:		20151104

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTOR VEHICLE PARTS & ACCESSORIES [3714]
		IRS NUMBER:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		63 GREAT ROAD
		CITY:			MAYNARD
		STATE:			MA
		ZIP:			01754
		BUSINESS PHONE:		(978) 938-0338

	MAIL ADDRESS:	
		STREET 1:		63 GREAT ROAD
		CITY:			MAYNARD
		STATE:			MA
		ZIP:			01754

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dutia Suren G
		CENTRAL INDEX KEY:			0001514063

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55532
		FILM NUMBER:		151196676

	MAIL ADDRESS:	
		STREET 1:		C/O CITIUS PHARMACEUTICALS, INC.
		STREET 2:		63 GREAT ROAD
		CITY:			MAYNARD
		STATE:			MA
		ZIP:			01754
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2015-10-08-06:00</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001506251</issuerCik>
        <issuerName>Citius Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>CTXR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001514063</rptOwnerCik>
            <rptOwnerName>Dutia Suren G</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CITIUS PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>63 GREAT ROAD</rptOwnerStreet2>
            <rptOwnerCity>MAYNARD</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>01754</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>false</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable></nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Options to Purchase Common Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.54</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2025-10-08-06:00</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>400000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option granted shall vest and become exercisable as follows: the option to purchase 40,000 shares of common stock of the Company (the &quot;Common Stock&quot;) vested on October 8, 2015, and the balance of the option, or the option to purchase 360,000 shares of Common Stock shall vest in twelve (12) equal installments commencing on December 31, 2015, provided that the Reporting Person continues to serve as a member of the Company's Board of Directors as of those dates. The maximum number of shares of Common Stock subject to the grant shall be 400,000. The Option was issued pursuant to the Company's 2014 Stock Incentive Plan.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Suren Dutia</signatureName>
        <signatureDate>2015-11-04-07:00</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
